Dr. El Hadri is the Founder, Chief Executive & Scientific Officer of CarboMimetics SAS, with over 25 years of experience in Drug Discovery within the pharmaceutical and biotech companies. An experience in a wide set of target types and therapeutic areas in particular in oncology and thrombosis diseases with successful track record of patented and developed programs. He is a committed self-starter life sciences executive with a large experience in managing projects in an international and VC-funded environment.

Dr El Hadri was the former Head of Chemistry Department and R&D Projects at Endotis Pharma (Fr) between 2008 and 2012. He’s a co-inventor of various sugar-based drug candidates that were advanced into preclinical stage. From 2000 to 2008, he held several positions at Argenta Discovery (UK), and CEREP (Fr).

Dr. El Hadri holds a Ph.D. in medicinal chemistry from the Faculty of Pharmacy – University of Grenoble, France and did his postdoctoral work in both industrial and Academic laboratories, Virbac (Fr) and ICSN-CNRS, Gif Sur Yvette (Fr).